India, May 13 -- Assertio Holdings, Inc. (ASRT), on Wednesday, announced that Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences Ltd. (ZYDUSLIFE.BO,ZYDUSLIFE.NS), agreed to acquire Assertio for approximately $166.4 million in cash, or $23.50 per share.
The transaction is expected to close in the second quarter of 2026.
The offer represents a 30.6% premium to the $18 per share all-cash transaction with GUARD.ST announced on April 8.
The offer also represents a 7.8% premium to the revised $21.80 per share Garda transaction announced on May 4.
The transaction further represents a 75.8% premium to Assertio's unaffected closing stock price on March 20.
The company also said that the board determined that the Zydus offer constituted a ...